Table 4.
Open in new tab

Results of percent survival according to the extent of the disease

Patients (n)5-y survival (%)10-y survival (%)
Entire cohort overall survival (OS)6717145.1
Lung metastases only20291.485.3
Normal X-ray and computed tomography3593.893.8
Micronodular13093.385.7
Macronodular3767.928
Bone metastases only2946331.9
Single3875.650.4
Multiple25661.228.4
Multiorgan17560.626.8
Patients (n)5-y survival (%)10-y survival (%)
Entire cohort overall survival (OS)6717145.1
Lung metastases only20291.485.3
Normal X-ray and computed tomography3593.893.8
Micronodular13093.385.7
Macronodular3767.928
Bone metastases only2946331.9
Single3875.650.4
Multiple25661.228.4
Multiorgan17560.626.8

Total numbers are highlighted as bold.

Table 4.
Open in new tab

Results of percent survival according to the extent of the disease

Patients (n)5-y survival (%)10-y survival (%)
Entire cohort overall survival (OS)6717145.1
Lung metastases only20291.485.3
Normal X-ray and computed tomography3593.893.8
Micronodular13093.385.7
Macronodular3767.928
Bone metastases only2946331.9
Single3875.650.4
Multiple25661.228.4
Multiorgan17560.626.8
Patients (n)5-y survival (%)10-y survival (%)
Entire cohort overall survival (OS)6717145.1
Lung metastases only20291.485.3
Normal X-ray and computed tomography3593.893.8
Micronodular13093.385.7
Macronodular3767.928
Bone metastases only2946331.9
Single3875.650.4
Multiple25661.228.4
Multiorgan17560.626.8

Total numbers are highlighted as bold.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close